Literature DB >> 6687778

Protein requirements in infants and children: a longitudinal study of children treated for phenylketonuria.

E Kindt, K Motzfeldt, S Halvorsen, S O Lie.   

Abstract

Two groups of children with phenylketonuria were followed from birth for several years. The Recommended Dietary Allowance group received a protein intake as recommended by the Food and Nutrition Board. The Food and Agricultural Organization (FAO) group received a protein intake as recommended by FAO. The children were followed very closely for the biochemical control of the disease. The children were also followed very closely to evaluate the adequacy of the protein intake using length, weight, routine hematology, chemical analysis, and x-ray of the hand. The results indicated two groups of healthy children. However, a decline in length growth percentile was found in some of the FAO children. A possible osteoporosis developed in two of the FAO children. The possible conclusion that the FAO "safe level of intakes of egg or milk protein" is marginal is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687778     DOI: 10.1093/ajcn/37.5.778

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  8 in total

1.  Does a marginal protein intake result in osteoporosis?

Authors:  E Kindt; S Halvorsen; S O Lie
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

2.  Six-year follow up of phenylalanine intakes and plasma phenylalanine concentrations.

Authors:  U Wendel; K Ullrich; H Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

Review 3.  An approach to protein restriction in children with renal insufficiency.

Authors:  N G Raymond; J T Dwyer; P Nevins; P Kurtin
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

Review 4.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

5.  Long-Term Growth in Phenylketonuria: A Systematic Review and Meta-Analysis.

Authors:  Fatma Ilgaz; Alex Pinto; Hülya Gökmen-Özel; Julio César Rocha; Esther van Dam; Kirsten Ahring; Amaya Bélanger-Quintana; Katharina Dokoupil; Erdem Karabulut; Anita MacDonald
Journal:  Nutrients       Date:  2019-09-03       Impact factor: 5.717

Review 6.  Protein Substitutes in PKU; Their Historical Evolution.

Authors:  Anne Daly; Sharon Evans; Alex Pinto; Catherine Ashmore; Anita MacDonald
Journal:  Nutrients       Date:  2021-02-02       Impact factor: 5.717

Review 7.  Glycomacropeptide in PKU-Does It Live Up to Its Potential?

Authors:  Anne Daly; Alex Pinto; Sharon Evans; Anita MacDonald
Journal:  Nutrients       Date:  2022-02-14       Impact factor: 5.717

Review 8.  Protein Substitute Requirements of Patients with Phenylketonuria on BH4 Treatment: A Systematic Review and Meta-Analysis.

Authors:  Fatma Ilgaz; Cyril Marsaux; Alex Pinto; Rani Singh; Carmen Rohde; Erdem Karabulut; Hülya Gökmen-Özel; Mirjam Kuhn; Anita MacDonald
Journal:  Nutrients       Date:  2021-03-23       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.